Protective effect of albumin on VEGF and brain edema in acute ischemia in rats

Neuroscience Letters

Volumn 472, Issue 3, 2010, Pages 179-183

  Yao, Xiaomei ^a   Miao, Wei ^b   Li, Min ^a   Wang, Min ^a   Ma, Jun ^a   Wang, Yongming ^a   Miao, Li ^c   Feng, Hong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Cangzhou Chinese and Western Medical Hospital   (China)

^c TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

Albumin; Brain edema; Middle Cerebral Artery Occlusion (MCAO); Vascular endothelial growth factor (VEGF)

Indexed keywords

HUMAN SERUM ALBUMIN; VASCULOTROPIN;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WATER CONTENT;

ACUTE DISEASE; ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SERUM ALBUMIN; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77649272931     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.002     Document Type: Article

References (30)

1. Belayev L., Alonso O.F., Busto R., Zhao W., and Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27 (1996) 1616-1622
2. Belayev L., Liu Y., Zhao W., Busto R., and Ginsberg M.D. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32 (2001) 553-560
3. Dziedzic T., Slowik A., and Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 35 (2004) e156-158
4. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
5. Foster K.A., Regan H.K., Danziger A.P., Detwiler T., Kwon N., Rickert K., Lynch J.J., and Regan C.P. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor. Neurosci. Res. 63 (2009) 10-16
6. Ginsberg M.D. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture. Stroke 34 (2003) 214-223
7. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55 (2008) 363-389
8. Ginsberg M.D., Hill M.D., Palesch Y.Y., Ryckborst K.J., and Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-I. Physiological responses and safety results. Stroke 37 (2006) 2100-2106
9. Hayashi T., Abe K., Suzuki H., and Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28 (1997) 2039-2044
10. i. Am. J. Physiol. 265 (1993) H74-H82
11. Holbeck S., and Grände P.O. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle. Crit. Care Med. 28 (2000) 1089-1095
12. Ishima Y., Kraqh-Hansen U., Maruyama T., and Otaqiri M. Albumin as a nitric oxide-traffic protein: characterization, biochemistry and possible future therapeutic applications. Drug Metab. Pharmacokinet. 24 (2009) 308-317
13. Issa R., Krupinski J., Bujny T., Kumar S., Kaluza J., and Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab. Invest. 79 (1999) 417-425
14. Jacob M., Chappell D., Conzen P., Wilkes M.M., Becker B.F., and Rehm M. Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit. Care 12 (2008) R34
15. Katavetin P., Inagi R., Miyata T., Tanaka T., Sassa R., Ingelfinger J.R., Fujita T., and Nangaku M. Albumin suppresses vascular endothelial growth factor via alteration of hypoxia-inducible factor/hypoxia-responsive element pathway. Biochem. Biophys. Res. Commun. 367 (2008) 305-310
16. Keaney J.F.J., Simon D.I., Stamler J.S., Jaraki O., Scharfstein J., Vita J.A., and Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91 (1993) 1582-1589
17. Lennmyr F., Terént A., Syvänen A.C., and Barbany G. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. Acta Anaesthesiol. Scand. 49 (2005) 488-493
18. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 (2001) 402-408
19. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20 (1989) 84-91
20. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol. 276 (1999) C1148-C1153
21. Palesch Y.Y., Hill M.D., Ryckborst K.J., Tamariz D., and Ginsberg M.D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-II. Neurologic outcome and efficacy analysis. Stroke 37 (2006) 2107-2114
22. Raghavendra Rao V.L., Dogan A., Bowen K.K., and Dempsey R.J. Ornithine decarboxylase knockdown exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Cereb. Blood Flow Metab. 21 (2001) 945-954
23. Remmers M., Schmidt-Kastner R., Belayev L., Lin B., Busto R., and Ginsberg M.D. Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats. Brain Res. 827 (1999) 237-242
24. Schoch H.J., Fischer S., and Marti H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125 (2002) 2549-2557
25. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., and D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271 (1996) 3877-3883
26. Tanaka Y., Koizumi C., Marumo T., Omura T., and Yoshida S. Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model. Brain Res. 1137 (2007) 140-145
27. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.P., van Lookeren Campagne M., and Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104 (1999) 1613-1620
28. Walberer M., Ritschel N., Nedelmann M., Volk K., Mueller C., Tschernatsch M., Stolz E., Blaes F., Bachmann G., and Gerriets T. Aggravation of infarct formation by brain swelling in a large territorial stroke: a target for neuroprotection?. J. Neurosurg. 109 (2008) 287-293
29. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., and Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106 (2000) 829-838
30. Zoellner H., Höfler M., Beckmann R., Hufnagl P., Vanyek E., Bielek E., Wojta J., Fabry A., Lockie S., and Binder B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J. Cell Sci. 109 (1996) 2571-2580